Shenzhen Lifotronic Technology Co (SHG:688389) — Market Cap & Net Worth
Market Cap & Net Worth: Shenzhen Lifotronic Technology Co (688389)
Shenzhen Lifotronic Technology Co (SHG:688389) has a market capitalization of $697.86 Million (CN¥4.77 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #10731 globally and #2961 in its home market, demonstrating a 2.58% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shenzhen Lifotronic Technology Co's stock price CN¥11.13 by its total outstanding shares 428485730 (428.49 Million). Also see balance sheet size of Shenzhen Lifotronic Technology Co for a full breakdown of the balance sheet.
Shenzhen Lifotronic Technology Co Market Cap History: 2019 to 2026
Shenzhen Lifotronic Technology Co's market capitalization history from 2019 to 2026. Data shows change from $995.99 Million to $697.86 Million (-7.47% CAGR). Also see Shenzhen Lifotronic Technology Co (688389) cash conversion ratio for how efficiently the company converts equity into cash flow.
Shenzhen Lifotronic Technology Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shenzhen Lifotronic Technology Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 688389 stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.78x
Shenzhen Lifotronic Technology Co's market cap is 0.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.37x
Shenzhen Lifotronic Technology Co's market cap is 4.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $995.99 Million | $422.64 Million | $100.56 Million | 2.36x | 9.90x |
| 2020 | $1.28 Billion | $553.82 Million | $143.95 Million | 2.31x | 8.89x |
| 2021 | $1.41 Billion | $778.11 Million | $190.35 Million | 1.81x | 7.42x |
| 2022 | $1.11 Billion | $983.04 Million | $251.48 Million | 1.13x | 4.40x |
| 2023 | $1.41 Billion | $1.15 Billion | $328.58 Million | 1.23x | 4.30x |
| 2024 | $933.62 Million | $1.15 Billion | $345.39 Million | 0.81x | 2.70x |
| 2025 | $813.86 Million | $1.04 Billion | $186.09 Million | 0.78x | 4.37x |
Competitor Companies of 688389 by Market Capitalization
Companies near Shenzhen Lifotronic Technology Co in the global market cap rankings as of September 24, 2026. Review tangible net worth ratio of Shenzhen Lifotronic Technology Co to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Shenzhen Lifotronic Technology Co by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Shenzhen Lifotronic Technology Co Historical Marketcap From 2019 to 2026
Between 2019 and today, Shenzhen Lifotronic Technology Co's market cap moved from $995.99 Million to $ 697.86 Million, with a yearly change of -7.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥697.86 Million | -14.25% |
| 2025 | CN¥813.86 Million | -12.83% |
| 2024 | CN¥933.62 Million | -33.85% |
| 2023 | CN¥1.41 Billion | +27.49% |
| 2022 | CN¥1.11 Billion | -21.57% |
| 2021 | CN¥1.41 Billion | +10.33% |
| 2020 | CN¥1.28 Billion | +28.46% |
| 2019 | CN¥995.99 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Shenzhen Lifotronic Technology Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $697.86 Million USD |
| MoneyControl | $697.86 Million USD |
| MarketWatch | $697.86 Million USD |
| marketcap.company | $697.86 Million USD |
| Reuters | $697.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shenzhen Lifotronic Technology Co
Shenzhen Lifotronic Technology Co., Ltd. researches, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. It offers a comprehensive range of in vitro diagnostic equipment and reagents, including electrochemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, specific protein analyzers, blo… Read more